Certican

Regular monitoring is required while you are on Certican 0.25mg Tablet. The doctor will advise blood tests to see the counts of red blood cells, white blood cells, and platelets since the counts may decrease during treatment with Certican 0.25mg Tablet. Also, blood tests will be required to check your kidney function, liver function, blood glucose levels, and cholesterol levels.

You should avoid grapefruit or grapefruit juice while taking Certican 0.25mg Tablet. This is because taking them together may increase the levels of Certican 0.25mg Tablet in your blood to harmful levels. Avoid the use of live vaccinations and any possible contact with individuals who have received live vaccinations.

Certican 0.25mg Tablet can cause serious side effects which include severe allergic reactions, angioedema, and kidney failure which can be severe and can lead to death. It is possible that you may develop an infection or problems related to lung such as breathing problems.

Certican 0.25mg Tablet is an anticancer medicine. It belongs to kinase inhibitor class of medicines. It works by reducing the blood supply to the tumor, which slows down the growth and spread of cancer cells.

Usually, Certican 0.25mg Tablet is taken once or twice daily. The medicine should always either be taken with food or always be taken without food. Certican 0.25mg Tablet should be swallowed whole with water and should not be crushed or chewed.

There is no definite duration of treatment with Certican 0.25mg Tablet. Certican 0.25mg Tablet is continued till clinical benefit is seen or unacceptable toxicity or side effects occur.

The effect of Certican 0.25mg Tablet in shrinking the size of tumor can only be checked by getting regular brain scans. It should be done as advised by your doctor and your treatment plan.

Yes, Certican 0.25mg Tablet is cytotoxic against human cancer cells of breast, stomach, prostate, and kidneys (renal cell carcinoma).